Charles Crecelius, MD
Geriatric Medicine · Saint Louis, MONPI 1215080312
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,325 of the $2,957 with a category attached, or 78.6%. 29 manufacturers reported payments, led by Biogen at 26.9% of the total. Reporting peaked in 2019 at $2,476 and has fallen 95.1% since, to $122 in 2025.
Across 166 payments — averaging $17.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$795
- Novo Nordisk$232
- Pfizer$205
- GSK$196
- AstraZeneca$169
- Amarin Pharma, Inc.$155
- plus $1K from 23 others
What the payments were for
- Travel & lodging$63221%
- Food & beverage$2,32579%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 5 | $795 |
| Novo Nordisk | 21 | $232 |
| Pfizer | 15 | $205 |
| GSK | 21 | $196 |
| AstraZeneca | 8 | $169 |
| Amarin Pharma, Inc. | 11 | $155 |
| Lilly USA, LLC | 20 | $143 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $139 |
| Neurocrine Biosciences, Inc. | 1 | $122 |
| Novartis | 8 | $111 |
| Sanofi-aventis U.S. LLC | 8 | $104 |
| Boehringer Ingelheim | 6 | $99 |
| E.r. Squibb & Sons, L.L.C. | 5 | $68 |
| AbbVie | 3 | $55 |
| Kowa Pharmaceuticals America, Inc. | 4 | $51 |
| Johnson & Johnson | 4 | $49 |
| Sunovion Pharmaceuticals Inc. | 3 | $44 |
| Astellas Pharma US Inc | 2 | $42 |
| Amgen | 2 | $34 |
| Acadia Pharmaceuticals Inc | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Adlon Therapeutics L.p. | 1 | $14 |
| Abbott | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $12 |
| Collegium Pharmaceutical, Inc. | 1 | $11 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$122
How this compares
$2,957 in reported general payments places this provider in the 85th percentile of 76 geriatric medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Autoshield Duo Pen NeedlePen Needle,dual Safety,diabetc | 147 | $7,391 |
| Lisinopril | 11 | $244 |
Paid to pharmacies, not to this prescriber.
Other geriatric medicine in Saint Louis
- Angela SanfordSaint Louis$15K
- Ellen BinderSaint Louis$4K
- Poonam JainSaint Louis$4K
- Uchenna OgbuokiriSaint Louis$3K
- Seema IyerSaint Louis$2K
- Hanish Sampath KumarSaint Louis$2K
- Richard OneillSaint Louis$1K
- Mark GunbySaint Louis$1K
- David CarrSaint Louis$1K
- Susan ReedsSaint Louis$725
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.